Professor Sherene Loi is a Medical Oncologist specialising in breast cancer treatment as well as a clinician scientist with expertise in genomics, immunology and drug development. She is the Head of the Translational Breast Cancer Genomics and Therapeutics laboratory at the Peter MacCallum Cancer Centre, Melbourne, as well as Consultant Medical Oncologist in the Breast Service and head of the Breast Cancer Clinical Trials Unit.
As a result of her research, Professor Loi has led a number of international breast cancer clinical trials in immunotherapy. She has published over 240 peer-reviewed research articles with a lifetime H index of 82 and recent work has been highly influential with 34,058 total citations and 25,117 (74%) within the past 5 years (Google Scholar).
Professor Loi Co-Chairs the Scientific Executive Committee and the Translational Working Group of the International Breast Cancer Study Group (IBCSG) based in Bern, Switzerland which conducts academic global breast cancer clinical trials in over 16 countries. She is the current holder of the Inaugural National Breast Cancer Foundation (NBCF) of Australia Endowed Chair and is a research fellow of the Breast Cancer Research Foundation (BCRF), New York.
Professor Loi was elected to the Breast Cancer Trials (BCT) Board of Directors in July 2020. She is a member of the BCT Scientific Advisory Committee and the Nominations Committee.